Medinotec Inc (MDNC) Return on Assets ROA from the second quarter of 2026 to second quarter of 2026 and for the year 2026, Average High and Low, Fundamental Ratios from Aug 31 2026 to Aug 31 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Medinotec Inc   (MDNC)


Medinotec Inc 's ROA from the second quarter of 2026 to the second quarter of 2026 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Medinotec Inc 's ROA in the second quarter of 2026?
Medinotec Inc achieved a return on average assets (ROA) of 6.52 % in its second quarter of 2026, which is below Medinotec Inc 's average return on assets, which stands at 13.79%.

ROA decreased relative to the period ending May 31 2026, due to the decline in net income.

However, within the Healthcare sector 105 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the first quarter of 2026 from 134 to 518.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Aug 31 2026)
II. Quarter		 (May 31 2026)
I. Quarter		 (Feb 28 2026)
IV. Quarter		 (Nov 30 2025)
III. Quarter		 (Aug 31 2025)
II. Quarter
Y / Y Total Assets Change 71.89 % 46.43 % 0.42 % 23.61 % 19.84 %
Y / Y Net Income Change -88.21 % 95.12 % - 30 % 21.71 %
Net Income (TTM) in million 1 1 1 2 2
Return On Assets (TTM) 6.52 % 11.27 % 11.1 % 32.74 % 33.24 %
MDNC's Total Ranking # 518 # 134 # 126 # 113 # 106
Total Assets (TTM) in million 11 11 7 8 6
Seq. Total Assets Change 1.05 % 58.75 % -16.18 % 27.83 % -13.91 %
Seq. Net Income Change -81.59 % - - 16.4 % 204.58 %

MDNC's 5 Years Annual ROA >> Back to MDNC Management Effectiveness >> Compare MDNC ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 32
Sector # 106
Overall # 709

Return On Assets Statistics
High Average Low
40.68 %
13.79 %
-10.28 %
(Feb 28 2025)   (Feb 29 2024)





Financial Statements
Medinotec Inc 's Assets $ 11 million MDNC's Balance sheet
Medinotec Inc 's Income $ 0 million Quarterly MDNC's Income Statement
MDNC's Income by Division See MDNC's Income by Division



Annual Return On Assets (Feb 28 2026)
FY 2026		 (Feb 28 2025)
FY 2025		 (Feb 29 2024)
FY 2024		 (Feb 28 2023)
FY 2023
FY
Y / Y Total Assets Change 0.42 % 40.95 % 78.52 % - -
Total Assets in million 7 7 5 3 0
Y / Y Net Income Change -63.21 % - - - -
Net Income in million 1 2 0 0 0
Annual Return On Assets 11.68 % 31.89 % -8.42 % -13.11 % -

MDNC's 5 Years Annual ROA >> Back to MDNC Management Effectiveness >> Compare MDNC ROA to its Competitors



Comment on MDNC's ROA in the fiscal year ending 2026
In the fiscal year 2026 Medinotec Inc 's ROA decreased compared to previous year to 11.68 %, due to deterioration of net income -63.21 % to $0.79 million, from $2.16 million a year ago, as MDNC's assets were $6.80 million.


More Return On Assets Ratios
MDNC's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
MDNC's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for MDNC's Competitors
Subscribers only: Roa for Medinotec Inc 's Suppliers
Subscribers only: Return On Assets for MDNC's Customers

You may also want to know
MDNC's Roi MDNC's Inventory Turnover Ratio MDNC's Growth Rates MDNC's Dividend Comparisons
MDNC's Profitability Ratios MDNC's Asset Turnover Ratio MDNC's Dividend Growth
MDNC's Roe MDNC's Valuation Ratios MDNC's Financial Strength Ratios MDNC's Dividend Payout Ratio



Companies with similar Return On Assets at Aug 31 2026, within Healthcare Sector ROA
Chemed Corporation  17.73 %
Halozyme Therapeutics Inc   17.26 %
Pro dex Inc   16.75 %
Denali Therapeutics Inc   16.42 %
Krystal Biotech Inc   15.48 %
West Pharmaceutical Services Inc   15.47 %
Dexcom Inc   15.47 %
Intuitive Surgical Inc   14.71 %
Vertex Pharmaceuticals Inc  14.16 %
Neurocrine Biosciences Inc   13.69 %
Illumina Inc   13.43 %
Healthcare Services Group Inc   12.79 %
Kiniksa Pharmaceuticals International Plc  12.64 %
Tenet Healthcare Corp  12.39 %
Hca Healthcare Inc   11.73 %
Carlisle Companies Incorporated  11.72 %
Regeneron Pharmaceuticals Inc   11.50 %
Lantheus Holdings Inc   11.43 %
Msa Safety Inc  11.01 %
Encompass Health Corporation  10.99 %
Inspire Medical Systems inc   10.89 %
Transmedics Group Inc   10.67 %
Bristol myers Squibb Company  10.47 %
Lemaitre Vascular Inc   10.28 %
Beone Medicines Ltd   10.23 %
Amgen Inc   10.02 %
Bio rad Laboratories Inc   9.88 %
3m Company  9.60 %
Bioventus Inc   9.47 %
Medinotec Inc   8.67 %

Date modified: 2026-10-09T04:24:49+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.